1st ESU-ESUT Masterclass on Focal therapy for localised prostate cancer8-9 December 2016, Paris, France
Several studies have shown the promising oncological results of Focal Therapy (FT) in the management of localised Prostate Cancer (PCa). FT is an alternative to radical treatments, which are associated with toxicity and negative side effects.
The 1st ESU-ESUT Masterclass on Focal Therapy for Localised Prostate Cancer will offer an intensive and interactive program dedicated to FT. To be held in Paris, France from 8 to 9 of December, this masterclass will provide a comprehensive review of the rationale for FT and the modalities of patients selection.
Since imaging is important in tumour detection, mpMRI modalities and various tools (e.g. MRI fusion software used in improving the diagnosis of PCa with targeted biopsies) will be examined during the masterclass. Several energy sources suitable for treatment, such as cryotherapy, high intensity focused ultrasounds, brachytherapy, the interstitial laser, vascular photodynamic therapy or the irreversible electroporation, will also be studied. Then post-treatment monitoring, failure diagnostic and management will be considered.
For optimal understanding, pre-recorded videos of targeted biopsy and focal ablative treatments using HIFU, cryotherapy and brachytherapy will be reviewed. In addition, hands-on training sessions will be provided by experts.
This masterclass is intended for urologists, radiologists and residents whose specialty/specialties are in the field of localised PCa.
We look forward to your participation in Paris!
Share this masterclass with your colleagues:
The masterclass will showcase improvements in PCa diagnosis include new techniques of biopsy; new modalities of treatment with new tools to improve accuracy of treatments; and development of new energies (e.g. athermal energies) to further limit the risks of side effects, to name a few.
Interactive and informative hands-on training courses will be administered by the experts of the field for further and optimal understanding of FT.
One of the core aims of this masterclass is to review the appropriateness of FT according to the characteristics of a patient’s cancer.